These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8972883)

  • 1. Measurement of DNA adducts in humans after complex mixture exposure.
    Dale CM; Garner RC
    Food Chem Toxicol; 1996 Sep; 34(9):905-19. PubMed ID: 8972883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32P-postlabeling analysis of DNA adducts.
    Phillips DH; Hewer A; Arlt VM
    Methods Mol Biol; 2005; 291():3-12. PubMed ID: 15502206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K; Anna L; Rudnai P; Schoket B
    Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of DNA modifications by the 32P-postlabelling assay.
    Phillips DH
    Mutat Res; 1997 Aug; 378(1-2):1-12. PubMed ID: 9288880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures.
    Van Schooten FJ; Godschalk RW; Breedijk A; Maas LM; Kriek E; Sakai H; Wigbout G; Baas P; Van't Veer L; Van Zandwijk N
    Mutat Res; 1997 Aug; 378(1-2):65-75. PubMed ID: 9288886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study.
    Baan RA; Steenwinkel MJ; van Asten S; Roggeband R; van Delft JH
    Mutat Res; 1997 Aug; 378(1-2):41-50. PubMed ID: 9288884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adduct measurements in zebra mussels, Dreissena polymorpha, Pallas. Potential use for genotoxicant biomonitoring of fresh water ecosystems.
    Le Goff J; Gallois J; Pelhuet L; Devier MH; Budzinski H; Pottier D; André V; Cachot J
    Aquat Toxicol; 2006 Aug; 79(1):55-64. PubMed ID: 16780971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.
    Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ
    Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunoaffinity chromatography enrichment and nuclease P1 procedures for 32P-postlabelling analysis of PAH-DNA adducts.
    Randerath K; Sriram P; Moorthy B; Aston JP; Baan RA; van den Berg PT; Booth ED; Watson WP
    Chem Biol Interact; 1998 Mar; 110(1-2):85-102. PubMed ID: 9566727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Phillips DH; Arlt VM
    Methods Mol Biol; 2020; 2102():291-302. PubMed ID: 31989562
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomonitoring human exposure to environmental carcinogenic chemicals.
    Farmer PB; Sepai O; Lawrence R; Autrup H; Sabro Nielsen P; Vestergård AB; Waters R; Leuratti C; Jones NJ; Stone J; Baan RA; van Delft JH; Steenwinkel MJ; Kyrtopoulos SA; Souliotis VL; Theodorakopoulos N; Bacalis NC; Natarajan AT; Tates AD; Haugen A; Andreassen A; Ovrebø S; Shuker DE; Amaning KS; Castelain P
    Mutagenesis; 1996 Jul; 11(4):363-81. PubMed ID: 8671761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution of DNA adducts in male Fischer rats exposed to 500 ppm of propylene oxide: quantitative analysis of 7-(2-hydroxypropyl)guanine by 32P-postlabelling.
    Segerbäck D; Plná K; Faller T; Kreuzer PE; Hakansson K; Filser JG; Nilsson R
    Chem Biol Interact; 1998 Oct; 115(3):229-46. PubMed ID: 9851292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological significance of DNA adducts: summary of discussions with an expert panel.
    Nestmann ER; Bryant DW; Carr CJ
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):9-18. PubMed ID: 8921541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the origins and development of the (32)P-postlabelling assay for carcinogen-DNA adducts.
    Phillips DH
    Cancer Lett; 2013 Jun; 334(1):5-9. PubMed ID: 23178450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
    Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
    Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearance of artefacts when using 32P-postlabelling to investigate DNA adduct formation by bile acids in vitro: lack of evidence for covalent binding.
    Scates DK; Spigelman AD; Venitt S
    Carcinogenesis; 1995 Jul; 16(7):1489-91. PubMed ID: 7614681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ³²P-postlabeling analysis of DNA adducts.
    Phillips DH; Arlt VM
    Methods Mol Biol; 2014; 1105():127-38. PubMed ID: 24623224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.